Prof G. Andre Ng

Professor G. André Ng

Professor Ng trained in Glasgow where he obtained his medical degree and subsequently PhD and then moved to Birmingham as clinical lecturer. He was appointed as Senior Lecturer in Cardiology at the University of Leicester in 2002 and Consultant Cardiologist and Electrophysiologist at the University Hospitals of Leicester.

Professor Ng is an expert in the management of cardiac arrhythmias especially in catheter ablation and the use of mapping systems in such procedures. He has played a key role in the establishment of an active ablation programme for atrial fibrillation since 2002 at Glenfield Hospital with excellent clinical results. He also specialises in device implantation including pacemakers, implantable cardioverter defibrillators and cardiac resynchronisation therapy (CRT) devices.

Professor Ng has a distinguished research profile in investigations into cardiac electrophysiology and arrhythmia mechanisms, leading both non-clinical and clinical teams of talented researchers. He is also Director of pan-European training programmes on advanced three-dimensional mapping systems and arrhythmia ablation.

Dr Will Nicolson

Dr Will Nicolson

Dr Nicolson graduated from Leeds University Medical School in 2001 and worked in various London hospitals before moving to the East Midlands in 2005. Dr Nicolson has been a Consultant Cardiologist at University Hospitals of Leicester NHS Trust since 2014.

For 3 years he was an NIHR Clinical Research Fellow at the Leicester Cardiovascular Biomedical Research Unit. Dr Nicolson won a prestigious Young Investigator Prize at the annual Heart Rhythm Congress 2011 for his LifeMap work. This is a personal “hat-trick” having won a Young Investigators’ Award at CardioRhythm in Hong Kong in February and the East Midlands Engineering and Science Professionals Master’s Prize in May.

Dr Nicolson performed the three proof of concept studies and wrote the first versions of the complex digital signal processing software LifeMap uses. Dr Nicolson has gone on to run multiple clinical trials of LifeMap in particular the multicentre MINERVA study which is in the final stages of recruitment.

Dr Fernando S. Schlindwein

Dr Fernando S. Schlindwein

Dr Schlindwein graduated with a First Class Honours degree as an Electrical / Electronic Engineer in 1979 from the Federal University of Rio Grande do Sul, Brazil, with an extension degree in Nuclear Engineering. He then obtained an MSc (Distinction) in Biomedical Engineering from the Coordination of Post-Graduation Programmes in Engineering of the Federal University of Rio de Janeiro (COPPE/UFRJ), Brazil in 1982, a PhD in Biomedical Engineering from the Department of Surgery of the University of Leicester, England in 1990, and a DSc in Biomedical Engineering from the Federal University of Rio de Janeiro (UFRJ) in 1992.

Dr. Schlindwein is an expert on signal processing with 40 years’ experience. He is a Reader at the School of Engineering of the University of Leicester, where he leads Bioengineering Research. His main research interest is real-time digital signal processing and he leads the Biomedical Engineering team from the School of Engineering associated with LifeMap and other research in the area of cardiac arrhythmias. He has published 90+ papers in refereed journals and 210+ papers in refereed scientific meetings. He has successfully supervised 16 research students at PhD level (as main supervisor), 33 at Master’s level and examined more than 50 PhDs. He has spent a sabbatical semester as a Visiting Scientist at the Department of Biomedical Engineering of The Johns Hopkins University, Baltimore, USA, doing research on heart rate variability and asphyxia. Dr Schlindwein is a Chartered Engineer, a Senior Fellow of the HEA, a member of the IEEE, the Institute of Physics and Engineering in Medicine (where he serves on the panel for accreditation of MSc courses in Bioengineering and Medical Physics) and the Brazilian Society of Biomedical Engineering. As well as refereeing research projects for the UK Research Councils (EPSRC and MRC), he serves on the referee panels of the Research Councils of Portugal and the Czech Republic.

Dr Xin Li

Dr Xin Li

Dr. Xin Li obtained BEng in Electrical Information Engineering from the University of Science and Technology Beijing 2011 and MSc in Electrical Electronic Engineering from the University of Leeds in 2012. He has been awarded his PhD in Biomedical Engineering from the University of Leicester in 2016. He was appointed as Research Associate from 2016 and promoted to Lecturer in 2019 at Departments of Cardiovascular Sciences and Engineering, University of Leicester, UK.

His research focused on using advanced signal processing and mathematical intelligent algorithms for improving target identification for catheter ablation during human persistent atrial fibrillation and better risk assessment for sudden cardiac death.

Dr Carl Edwards

Dr Carl Edwards

Carl graduated in Microbiology from The University of Aberystwyth and moved on to obtain a PhD from The University of Leicester. His research included blood coagulation and renal transplant surgery, assisting in the management of clinical trials within the Department of Surgery.  He completed postdoctoral research at the University of Nottingham developing synthetic oxygen carriers for use as blood substitutes prior to moving on to commercial roles.

Carl is an experienced commercial development manager who has provided consultancy services to pharmaceutical, medical devices companies and venture capital funds.  He has worked with companies including Merck, AstraZeneca, 3M and Baxter delivering clinical development plans and investment support. Carl was Director of NHS Innovations East Midlands, responsible for IP exploitation from all NHS Trusts in the region and has also delivered technology transfer at Imperial Innovations and Cranfield University.

Carl Joined LPMI as Commercial Manager in January 2018 and is responsible for engaging with commercial partners and facilitating industry led research collaborations in precision medicine.  He is also providing IP and commercialisation advice to LPMI members, assisting in building a broad base of collaborations for LMPI.  Carl is the UK lead for the CODEX4SME European programme to assist SMEs in developing companion diagnostics, providing networking events and access to clinical experts as part of the package of support.

About Us

LifeMap diagnostics is based in Leicester, UK and includes a team of researchers and clinicians.

What is LifeMap?

LifeMap is a quick, minimally invasive test that has been shown to precisely assess risk of sudden cardiac death.

LifeMap Success

LifeMap has won numerous awards and Research Grants because of its novelty and efficacy.

Evidence for LifeMap?

LifeMap has been detailed in 3 peer reviewed published studies with further publications being finalised.